Research & Development: Page
-
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Opinions Six Sigma: A Process Strategy The vision for Six Sigma is not just about bottom-line savings. Within the last few years, Six Sigma programs have become geared toward stimulating top-line growth by focusing on critical aspects of company-centric design processes. PharmaVOICE asked: Does y...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents September 2005 On the Cover Pharmaceutical industry image: Regaining the trust Repairing the pharmaceutical industry’s tarnished image is a major undertaking that many believe has barely begun. All sectors of the industry need to unite behind a single message and purpose: to res...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In June, PharmaVOICE hosted its first Pharmaceutical Marketers KnowledgeShare Forum, a two-day event that brought together top-level executives from throughout the industry to engage in a meaningful dialogue on a number of subjects impacting the marketing sector. On the second day of this event, ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Commanders and Chiefs
PharmaVOICE 100 These top-level executives are at the forefront, leading change within the industry and guiding their companies to success. Guided by Values David Mott It has been said that how individuals respond to adversity often defines their character. David Mott, president, CEO, and vice ch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Risk Takers
Taking the World by Storm Five years ago, during a cab ride in New York City the idea for the Institute for OneWorld Health, the nation’s only nonprofit pharmaceutical company, was born. The African cabbie’s comment that pharmaceutical companies have all the money ignited the fire. The passenger ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents The Commanders and Chiefs From the presidents of major pharmaceutical companies to top executives at specialty and biotechnology companies to the leaders of companies that support the industry, these men and women are shaping the life-sciences industry. The Risk Takers The archi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The CRA: A Key to Site Effectiveness
The CRA: A Key to Site Effectiveness Clinical Research Associates By Denise Myshko Electronic data capture and other clinical-research technologies are having a far-reaching impact that extends beyond just the quick and efficient gathering of data. Clinical research associates — employed by the s...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The PharmaVOICE 100 - Letter from the Editor
The PharmaVOICE 100 was inspired by the men and women who graciously consent to share their insights on the various trends and challenges facing the life-sciences industry on a monthly basis. We are continually fired up by their knowledge and willingness to raise their voices and bring their uniq...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
July 18-19 The 2nd Annual Strategic Medicare Compliance and Administration Summit Ritz Carlton Hotel, Tysons Corner, Va. For more information, contact Jon Stock, The Center for Business Intelligence, at 800-817-8601, e-mail [email protected], or visit cbinet.com. July 18-19 9th International Out...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Letters Are Drug Safety Concerns Endangering Drug Benefits? The best way to avoid draconian restrictions on consumer and doctor access to the world’s most innovative medicines is to strike an appropriate balance between benefits and risks. — Rob Norton A Congressional overreaction For starters, I...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Dorland Launches inRx Medical Education Independent company formed to respond to increasing regulatory standards. In response to growing concerns about regulatory oversight and the need to separate continuing medical-education programs from company-sponsored marketing activities, Dorland has crea...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
PharmaTrax Worldwide Hormonal Contraceptive Market to Increase The world market for hormonal contraceptive products will surpass $6 billion in 2005, according to a new report from Kalorama Information. The report, Markets in Human Reproductive Medicine: Contraception and Infertility Management, c...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Richard Pascoe -- An Officer & A Leader
An Officer & A Leader July 2005 From the military to the semiconductor industry to the life-sciences industry, Richard Pascoe has drawn on his leadership skills — team building and staff motivation, combined with courage, integrity, and character — to bring out the best in his people for the ...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Teri Cox says the public isn’t aware of the industry’s role in patient advocacy. Dr. Paul Bleicher says it’s important to consider what components of a CRO will be used when determining budgets. Contents Richard Pascoe says leadership is understanding what motivates people. July 2005 On the Cover...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool July 2005 Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Marcus Carr Novo Nordisk Names Chief Medical Officer Marcus Carr, M.D., Ph.D., has joined Novo Nordisk as chief medical officer and executive director for clinical research of the hemostasis gro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Communicating cooperatively Letter from the Editor July 2005 In June, an unprecedented number of exhibitors and attendees convened in Washington, D.C., to attend the annual Drug Information Association (DIA) conference. The DIA annual meeting provides a neutral forum for regulators, academics, an...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Dendrite Launches Sample Program Dendrite International Inc. has launched its One-Source Sample program, which serves the entire life cycle of sample-product promotion and blends market-leading software applications with best-in-class consulting and professional services. Helping to ensure compli...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCounsel
The Effects of the HIPAA Privacy Policy Rule on Clinical Research and Registries On April 14, 2003, the privacy rule took effect and most covered entities must now comply with its provisions. The rule establishes minimum federal standards for safeguarding the privacy of individually identifiable ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Industry Events October 15-16, 2003, Wardman Park Marriott Hotel — Washington, D.C. eSubmissions for Global Compliance This Marcus Evans conference will focus on electronic document management and publishing. Key topics will include an ICH update, changes in eCTD specifications, CDISC data standa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents Letter from the Editor Forum on Marketing Modern Marketing in the Making: Marketing executives from pharmaceutical, biotechnology, device, and diagnostic companies, ranging in size from small specialty to midtier to large and global, share common challeng...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover The time for transparency The government, medical journal editors, and general public are clamoring for the pharmaceutical industry to provide complete information about ongoing and completed clinical trials. There has been a flurry of activity, announcements, and mandates in this ar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
June 6-7 Pharmaceutical Marketers KnowledgeShare Forum 2005: Building Brand Differentiation in the Current Regulatory Climate Airport Marriott, Philadelphia This is a PharmaVOICE event, subscribers are eligible for a 15% discount; register using code PVMKS05. For more information, contact Micah L...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-Media June 2005 PharmaVOICE SAS Upgrades Scientific Discovery Solutions In response to the need for modernization in the drug-development process, SAS Institute Inc. has made significant upgrades and additions to its Scientific ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical sch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Opinions What’s on your mind What have you heard lately? In the September issue of PharmaVOICE, we asked readers to relate the most surprising statistics or strange facts that they have come across. PharmaVOICE learned that every human spent about half an hour as a single cell and that 70% of con...
By PharmaVoice Team • Jan. 2, 2008
Previous
